|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
1 Robert Robinson Avenue,Oxford,Oxfordshire,GB
|
|
Enara Bio’s mission is to shine a light on unconventional targets and develop the next generation of cancer immunotherapies designed to treat a broad patient population. Enara Bio is exploring the hidden depths of cancer and T-cell biology to discover and characterize novel immunotherapy targets, such as MR1-presented ligands and Dark Antigens™, which arise from altered cellular processes in cancer cells. We are pioneering approaches to exploit these targets with TCR-directed therapy and other immunotherapeutic modalities. To achieve our mission, we are leveraging our differentiated MR1 ligand complex, Dark Antigen™ and TCR discovery platforms that integrate bioinformatics, immunopeptidomics, metabolomics and immunology in our Oxford, UK-based research lab alongside our extensive immunotherapy development expertise.
Enara Bio is backed by leading life science investors, including SV Health Investors, the founding investor, together with RA Capital and Samsara Biocapital. We have a major strategic partnership with Boehringer Ingelheim to discover and validate novel Dark Antigens in up to three tumor types and collaborate with a number of world-class academic institutions, including the Francis Crick Institute, Cardiff University, Johns Hopkins School of Medicine and the University of Oxford, to help drive our differentiated science.
|
Enara Bio Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Enara Bio email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Enara Bio customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.